has tirzepatide been approved for weight loss FDA Grants a New Indication Obesity Management The Science Behind Tirzepatide Medical
Description
Tirzepatide (Mounjaro, Zepbound) is not officially listed as causing increased thirst as a direct side effect in the FDA prescribing information
Espinosa, J
The challenge: eating enough protein with reduced appetite Here is the catch
Tesofensine Overview
The maximum dosing limit for tirzepatide is 15 mg once a week
